Boechat N - Search Results

1

Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives.

Pinheiro LCS, Feitosa LM, Silveira FFD, Boechat N. Pinheiro LCS, et al. Among authors: boechat n. An Acad Bras Cienc. 2018;90(1 Suppl 2):1251-1271. doi: 10.1590/0001-3765201820170830. An Acad Bras Cienc. 2018. PMID: 29873667 Free article. Review.

2

Design and synthesis of new N-(5-trifluoromethyl)-1H-1,2,4-triazol-3-yl benzenesulfonamides as possible antimalarial prototypes.

Boechat N, Pinheiro LC, Santos-Filho OA, Silva IC. Boechat N, et al. Molecules. 2011 Sep 20;16(9):8083-97. doi: 10.3390/molecules16098083. Molecules. 2011. PMID: 21934646 Free PMC article.

3

New trifluoromethyl triazolopyrimidines as anti-Plasmodium falciparum agents.

Boechat N, Pinheiro LC, Silva TS, Aguiar AC, Carvalho AS, Bastos MM, Costa CC, Pinheiro S, Pinto AC, Mendonça JS, Dutra KD, Valverde AL, Santos-Filho OA, Ceravolo IP, Krettli AU. Boechat N, et al. Molecules. 2012 Jul 10;17(7):8285-302. doi: 10.3390/molecules17078285. Molecules. 2012. PMID: 22781441 Free PMC article.

4

New compounds hybrids 1h-1,2,3-triazole-quinoline against Plasmodium falciparum.

Boechat N, Ferreira Mde L, Pinheiro LC, Jesus AM, Leite MM, Júnior CC, Aguiar AC, de Andrade IM, Krettli AU. Boechat N, et al. Chem Biol Drug Des. 2014 Sep;84(3):325-32. doi: 10.1111/cbdd.12321. Epub 2014 Jun 5. Chem Biol Drug Des. 2014. PMID: 24803084

5

Novel selective inhibitor of Leishmania (Leishmania) amazonensis arginase.

da Silva ER, Boechat N, Pinheiro LC, Bastos MM, Costa CC, Bartholomeu JC, da Costa TH. da Silva ER, et al. Among authors: boechat n. Chem Biol Drug Des. 2015 Nov;86(5):969-78. doi: 10.1111/cbdd.12566. Epub 2015 May 14. Chem Biol Drug Des. 2015. PMID: 25845502

6

Anti-Plasmodium falciparum activity of quinoline-sulfonamide hybrids.

Pinheiro LC, Boechat N, Ferreira Mde L, Júnior CC, Jesus AM, Leite MM, Souza NB, Krettli AU. Pinheiro LC, et al. Among authors: boechat n. Bioorg Med Chem. 2015 Sep 1;23(17):5979-84. doi: 10.1016/j.bmc.2015.06.056. Epub 2015 Jul 2. Bioorg Med Chem. 2015. PMID: 26190461

7

Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry.

Bastos MM, Costa CCP, Bezerra TC, da Silva FC, Boechat N. Bastos MM, et al. Among authors: boechat n. Eur J Med Chem. 2016 Jan 27;108:455-465. doi: 10.1016/j.ejmech.2015.11.025. Epub 2015 Nov 25. Eur J Med Chem. 2016. PMID: 26708112 Review.

8

New pentasubstituted pyrrole hybrid atorvastatin-quinoline derivatives with antiplasmodial activity.

Carvalho RC, Martins WA, Silva TP, Kaiser CR, Bastos MM, Pinheiro LC, Krettli AU, Boechat N. Carvalho RC, et al. Among authors: boechat n. Bioorg Med Chem Lett. 2016 Apr 15;26(8):1881-4. doi: 10.1016/j.bmcl.2016.03.027. Epub 2016 Mar 9. Bioorg Med Chem Lett. 2016. PMID: 26988303

9

Design, synthesis and anti-P. falciparum activity of pyrazolopyridine-sulfonamide derivatives.

Silva TB, Bernardino AMR, Ferreira MLG, Rogerio KR, Carvalho LJM, Boechat N, Pinheiro LCS. Silva TB, et al. Among authors: boechat n. Bioorg Med Chem. 2016 Sep 15;24(18):4492-4498. doi: 10.1016/j.bmc.2016.07.049. Epub 2016 Jul 25. Bioorg Med Chem. 2016. PMID: 27485600 Free article.

10

New hydrazides derivatives of isoniazid against Mycobacterium tuberculosis: Higher potency and lower hepatocytotoxicity.

Castelo-Branco FS, de Lima EC, Domingos JLO, Pinto AC, Lourenço MCS, Gomes KM, Costa-Lima MM, Araujo-Lima CF, Aiub CAF, Felzenszwalb I, Costa TEMM, Penido C, Henriques MG, Boechat N. Castelo-Branco FS, et al. Among authors: boechat n. Eur J Med Chem. 2018 Feb 25;146:529-540. doi: 10.1016/j.ejmech.2018.01.071. Epub 2018 Jan 31. Eur J Med Chem. 2018. PMID: 29407978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page